That information came from the very article that runcaly posted.
While I agree that runcaly's heart is in the right place. I'm afraid that his effort, to the extent that anyone pays attention to him, is a distraction and waste of time.
The African distributor runcaly is in contact with should be spending his time addressing actual markets, not attempting to apply the test in an application where it is doomed to fail. We do not need another headline like: Calypte test gives 50% false positives in infants....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.